Improved Physical Function After Cardiac Contractility Modulation Therapy in 10 Patients With Chronic Heart Failure

Area of Science:

• Cardiology
• Biomedical Engineering
• Medical Devices

Background:

• Advanced heart failure management options are expanding with new therapeutic devices.
• Cardiac contractility modulation (CCM) therapy represents a novel approach for heart failure treatment.

Purpose of the Study:

• To evaluate the outcomes of cardiac contractility modulation therapy in patients with chronic heart failure.
• To assess the impact of CCM therapy on hemodynamics, functional capacity, and clinical outcomes.

Main Methods:

• Ten patients with chronic heart failure received nonrandomized cardiac contractility modulation therapy.
• Evaluations included hemodynamics, left ventricular ejection fraction, functional capacity (6-minute walk test), and clinical outcomes at baseline and 6 months.

Main Results:

• Left ventricular ejection fraction improved from 27.1% to 35.1%.
• New York Heart Association class improved from 3.9 to 2.44, and 6-minute walk test distance increased by 53.2 meters.
• Hospital admissions decreased from a mean of 2.4 to 1 within the 6 months post-therapy.

Conclusions:

• Cardiac contractility modulation therapy demonstrated significant improvements in physical functioning for heart failure patients.
• The therapy led to a notable reduction in hospital admissions, suggesting improved clinical outcomes.